Ask AI
H.R. 8339

Drug Origin Transparency Act of 2026

A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.

Referred to the House Committee on Energy and Commerce.

Rep. Matsui, Doris O. [D-CA-7](D-CA)Sponsor
3 cosponsors
Drug Origin Transparency Act of 2026 — Informed